ATEA PHARMACEUTICALS INC (AVIR) Stock Balance Sheet
NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 143.82M | 188.50M | 764.40M | 850.10M | 21.70M | |||
| Marketable Securities | 434.28M | 458.20M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 0.00 | 5.80M | N/A | |||
| Other Current Assets | 12.35M | 14.20M | 8.00M | 7.50M | 200.00K | |||
| Total Current Assets | 590.46M | 660.90M | 772.40M | 863.50M | 21.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.12M | 4.10M | 200.00K | 0.00 | 0.00 | |||
| Other Non-Current Assets | 1.40M | 1.70M | 300.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 4.51M | 5.80M | 500.00K | 100.00K | 200.00K | |||
| TOTAL ASSETS | 594.97M | 666.70M | 772.90M | 863.60M | 22.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 28.12M | 15.80M | 49.80M | 14.40M | 1.90M | |||
| Accounts Payable | 4.25M | 2.60M | 4.50M | 100.00K | 500.00K | |||
| Other Current Liabilities | 0.00 | 100.00K | 2.60M | 301.40M | N/A | |||
| Total Current Liabilities | 32.38M | 18.50M | 56.90M | 315.80M | 2.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 7.40M | 7.70M | 5.90M | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 7.40M | 7.60M | 5.90M | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 39.78M | 26.10M | 62.80M | 315.80M | 2.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -195.84M | -59.90M | 56.00M | -65.20M | -54.20M | |||
| Additional Paid In Capital | 750.74M | 701.10M | 654.00M | 612.90M | 4.60M | |||
| Common Shares | 83.00K | 100.00K | 100.00K | 100.00K | 69.10M | |||
| Other Shareholders' Equity | 207.00K | -700.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 83.44M | 83.30M | 83.10M | 82.40M | 80.70M | |||
| Tangible Book Value per Share | 6.65 | 7.69 | 8.55 | 6.65 | -0.61 | |||
| Total Shareholders' Equity | 555.19M | 640.60M | 710.10M | 547.80M | 19.50M | |||
| TOTAL LIABILITIES AND EQUITY | 594.97M | 666.70M | 772.90M | 863.60M | 22.10M | |||
| Statistics | ||||||||
| Current Ratio | 18.24 | 35.72 | 13.57 | 2.73 | 9.13 | |||
| Return On Assets (ROA) | -22.85% | -17.38% | 15.68% | -1.26% | -63.35% | |||
| Return On Equity (ROE) | -24.49% | -18.09% | 17.07% | -1.99% | -71.79% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 25.59% | 1.73% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21